These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 12823159

  • 1. The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity.
    Orr WC, Harnish MJ.
    Aliment Pharmacol Ther; 2003 Jun 15; 17(12):1553-8. PubMed ID: 12823159
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
    Castell D, Bagin R, Goldlust B, Major J, Hepburn B.
    Aliment Pharmacol Ther; 2005 Jun 15; 21(12):1467-74. PubMed ID: 15948814
    [Abstract] [Full Text] [Related]

  • 3. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors.
    Xue S, Katz PO, Banerjee P, Tutuian R, Castell DO.
    Aliment Pharmacol Ther; 2001 Sep 15; 15(9):1351-6. PubMed ID: 11552905
    [Abstract] [Full Text] [Related]

  • 4. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.
    Katz PO, Hatlebakk JG, Castell DO.
    Aliment Pharmacol Ther; 2000 Jun 15; 14(6):709-14. PubMed ID: 10848653
    [Abstract] [Full Text] [Related]

  • 5. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P, Thumshirn M, Menne D, Fox M, Halim S, Fried M, Brühlmann P, Distler O, Schwizer W.
    Aliment Pharmacol Ther; 2007 Nov 01; 26(9):1259-65. PubMed ID: 17944740
    [Abstract] [Full Text] [Related]

  • 6. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.
    Katz PO, Anderson C, Khoury R, Castell DO.
    Aliment Pharmacol Ther; 1998 Dec 01; 12(12):1231-4. PubMed ID: 9882031
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sleep-related gastro-oesophageal reflux: provocation with a late evening meal and treatment with acid suppression.
    Orr WC, Harnish MJ.
    Aliment Pharmacol Ther; 1998 Oct 01; 12(10):1033-8. PubMed ID: 9798810
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily.
    Hatlebakk JG, Katz PO, Kuo B, Castell DO.
    Aliment Pharmacol Ther; 1998 Dec 01; 12(12):1235-40. PubMed ID: 9882032
    [Abstract] [Full Text] [Related]

  • 18. Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood.
    Franco MT, Salvia G, Terrin G, Spadaro R, De Rosa I, Iula VD, Cucchiara S.
    Dig Liver Dis; 2000 Nov 01; 32(8):660-6. PubMed ID: 11142573
    [Abstract] [Full Text] [Related]

  • 19. Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease.
    Gardner JD, Sloan S, Miner PB, Robinson M.
    Aliment Pharmacol Ther; 2003 Apr 01; 17(7):945-53. PubMed ID: 12656697
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.